The detailed location data provided by SenseAware ID is a critical differentiator for healthcare industry customers, and FedEx expects to use this new technology with anticipated COVID-19 vaccine shipments. The rollout of SenseAware ID is well-timed as FedEx continues to move life-saving pharmaceuticals and medical supplies for healthcare customers throughout the U.S.
“Package tracking and visibility are more important now than ever, as businesses have become increasingly reliant on timely deliveries,” said Robert B. Carter, executive vice president and chief information officer, FedEx Corporation. “Created by our innovation teams at FedEx, SenseAware ID was designed to give our customers the precise level of tracking they’ve been looking for, enabling them to optimize their supply chains and make any necessary adjustments during the journey of their shipments.”
FedEx has long been a pioneer in sensor-based logistics, providing advanced tracking of urgent and high value shipments for over a decade through its proprietary SenseAware portfolio. SenseAware ID is the latest innovation in FedEx sensor technology, designed to make sensor-based logistics more accessible to FedEx customers.
SenseAware ID uses a lightweight, compact sensor that transmits precise package location data every two seconds via Bluetooth Low Energy (BLE) to WiFi access points or established gateway devices throughout the FedEx Express network. Packages equipped with the SenseAware ID sensor are tracked hundreds of times versus dozens of times with traditional package scanning protocols, which provides an unprecedented amount of real-time data about the location of the shipment.
As part of the initial roll-out, SenseAware ID sensors are being applied to First Overnight shipments within the U.S. domestic FedEx Express network. An initial round of customers in the healthcare, aerospace and retail industries will receive access to the enhanced data in November 2020. FedEx expects to expand access to this precision location data to additional customers throughout the first half of 2021. SenseAware ID will eventually be made available for a broad range of premium FedEx Express services.
The enhanced package visibility data provided by SenseAware ID will give FedEx healthcare customers the opportunity to closely monitor and proactively protect shipments using additional FedEx healthcare services, including cold-chain storage, thermal blankets and temperature controlled containers. SenseAware ID is expected to play a critical role in the distribution of COVID-19 vaccines using the FedEx First Overnight service, helping ensure these sensitive shipments are delivered quickly and safely.